The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Hayden Brian J since 2007.
The trader's CIK number is 1262224.
At the time of the last reporting, Hayden Brian J was the Other of Savient Pharmaceuticals Inc. (stock ticker symbol SVNT).
Also see all insider trading activities at Savient Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2009 | SVNT | 0 | $0 | 3,441 | $19,837 | 0 | $0 |
| 2008 | SVNT | 0 | $0 | 25,096 | $589,914 | 5,000 | $26,650 |
| 2007 | SVNT | 0 | $0 | 24,450 | $427,174 | 20,000 | $106,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2009-02-17 | SVNT | Sale | 3,441 | 5.76 | 19,837 |
| 2008-05-06 | SVNT | Sale | 5,000 | 24.00 | 120,000 |
| 2008-02-28 | SVNT | Sale | 5,000 | 24.06 | 120,295 |
| 2008-02-29 | SVNT | Sale | 2,279 | 24.00 | 54,696 |
| 2008-02-15 | SVNT | Sale | 2,817 | 19.98 | 56,278 |
| 2008-01-02 | SVNT | Option Ex | 5,000 | 5.33 | 26,650 |
| 2008-01-02 | SVNT | Sale | 5,000 | 23.47 | 117,360 |
| 2008-01-03 | SVNT | Sale | 5,000 | 24.26 | 121,285 |
| 2007-12-18 | SVNT | Option Ex | 5,000 | 5.33 | 26,650 |
| 2007-12-18 | SVNT | Sale | 5,000 | 20.09 | 100,440 |
| 2007-12-17 | SVNT | Option Ex | 5,000 | 5.33 | 26,650 |
| 2007-12-17 | SVNT | Sale | 5,000 | 19.91 | 99,535 |
| 2007-12-13 | SVNT | Option Ex | 5,000 | 5.33 | 26,650 |
| 2007-12-14 | SVNT | Option Ex | 5,000 | 5.33 | 26,650 |
| 2007-12-13 | SVNT | Sale | 5,000 | 17.18 | 85,890 |
| 2007-12-14 | SVNT | Sale | 5,000 | 17.12 | 85,595 |
| 2007-03-05 | SVNT | Sale | 4,450 | 12.52 | 55,714 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hayden Brian J (Other of Savient Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.